Combinations of trametinib, panitumumab and dabrafenib for the treatment of cancer
- 专利权人:
- Novartis AG
- 发明人:
- Greshock, Joel David,Hoos, Axel
- 申请号:
- AU2014362995
- 公开号:
- AU2014362995A1
- 申请日:
- 2014.12.11
- 申请国别(地区):
- AU
- 年份:
- 2016
- 代理人:
- 摘要:
- A novel combination comprising a B-Raf inhibitor, particularly
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- TARGETED THERAPIES FOR CANCER
- COMBINATIONS OF TRAMETINIB, PANITUMUMAB AND DABRAFENIB FOR THE TREATMENT OF CANCER
- Combination of trametinib, panitumumab and dabrafenib for the treatment of cancer
- COMBINATIONS OF TRAMETINIB, PANITUMUMAB AND DABRAFENIB FOR THE TREATMENT OF CANCER
- COMBINATIONS OF TRAMETINIB, PANITUMUMAB AND DABRAFENIB FOR THE TREATMENT OF CANCER